Atrial fibrillation ablation in heart failure: What do we know? What can we do?

Abstract Atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF) are two conditions that frequently impact reciprocally on each other. Patients with HFrEF have an increased risk of stroke, hospitalization and mortality after they develop AF and vice versa, AF causing deteri...

Full description

Saved in:
Bibliographic Details
Published inEuropace (London, England) Vol. 23; no. 3; pp. 353 - 361
Main Authors Chiocchini, Andrea, Terricabras, Maria, Verma, Atul
Format Journal Article
LanguageEnglish
Published England Oxford University Press 08.03.2021
Subjects
Heart failure
Review
Ablation
Atrial fibrillation
Catheter ablation
Online AccessGet full text

Cover

More Information
Summary:Abstract Atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF) are two conditions that frequently impact reciprocally on each other. Patients with HFrEF have an increased risk of stroke, hospitalization and mortality after they develop AF and vice versa, AF causing deterioration of the ejection fraction is also associated to increased mortality. Catheter ablation has emerged as an effective alternative to antiarrhythmic drug treatment to maintain sinus rhythm and some randomized trials have shown a potential benefit in terms of mortality and hospitalization. This review discusses the available evidence regarding catheter ablation treatment in this specific patient group.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1099-5129
1532-2092
DOI:10.1093/europace/euaa217